参考文献/References:
[1]胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要[J].中国循环杂志,2019,34(3):209-220.[2]Chrysant SG,Chrysant GS.The current status of homocysteine as a risk factor for cardiovascular disease:a mini review[J].Expert Rev Cardiovasc Ther,2018,16(8):559-565.[3]Dragan D,Vladimir J,Zivkovic VI,et al.Homocysteine and homocysteine-related compounds:an overview of the roles in the pathology of the cardiovascular and nervous systems[J].Can J Physiol Pharmacol,2018,96(10):991-1003.[4]Cohen E,Margalit I,Shochat T,et al.Gender differences in homocysteine concentrations,a population-based cross-sectional study[J].Nutr Metab Cardiovasc Dis,2019,29(1):9-14.[5]Omoike OE,Paul TK,Ridner SL,et al.Association between smoking status and homocysteine levels and possible effect modification by cholesterol and oestradiol[J].Biomarkers,2020,25(2):126-130.[6]McCully KS.Homocysteine and the pathogenesis of atherosclerosis[J].Expert Rev Clin Pharmacol,2015,8(2):211-219.[7]Xin T,Lei Z,Xianjing S,et al.HSP27 Inhibits Homocysteine-Induced Endothelial Apoptosis by Modulation of ROS Production and Mitochondrial Caspase-Dependent Apoptotic Pathway[J].BioMed Research International,2016(2016):1-9.[8]Zhang H,Wang Y,Cao C,et al.A regulatory circuit involving miR-143 and DNMT3a mediates vascular smooth muscle cell proliferation induced by homocysteine[J].Molecular Medicine Reports,2016,13(1):483-490.[9]Yang Z,Wang L,Zhang W,et al.Plasma homocysteine involved in methylation and expression of thrombomodulin in cerebral infarction[J].Biochem Biophys Res Commun,2016,473(4):1218-1222.[10]Li S,Pan G,Chen H,et al.Determination of Serum Homocysteine and Hypersensitive C-reactive Protein and Their Correlation with Premature Coronary Heart Disease[J].Heart Surg Forum,2019,22(3):215-217.[11]Nygard O,Nordrehaug JE,Refsum H,et al.Plasma homocysteine levels and mortality in patients with coronary artery disease[J].N Engl J Med,1997,337(4):230-236.[12]Homocysteine Studies Collaboration.Homocysteine,Homocysteine and Risk of Ischemic Heart Disease and Stroke:A Meta-analysis[J].JAMA,2002,288(16):2015-2022.[13]Han K,Lu Q,Zhu WJ,et al.Correlations of degree of coronary artery stenosis with blood lipid, CRP,Hcy,GGT,SCD36 and fibrinogen levels in elderly patients with coronary heart disease[J].Eur Rev Med Pharmacol Sci,2019,23(21):9582-9589.[14]Han L,Wu Q,Wang C,et al.Homocysteine, Ischemic Stroke, and Coronary Heart Disease in Hypertensive Patients:A Population-Based, Prospective Cohort Study[J].Stroke,2015,46(7):1777-1786.[15]Miao L,Deng GX,Yin RX,et al.No causal effects of plasma homocysteine levels on the risk of coronary heart disease or acute myocardial infarction:A Mendelian randomization study[J].Eur J Prev Cardiol,2019:2047487319894679.[16]Hiraoka M,Kagawa Y.Genetic polymorphisms and folate status[J].Congenital Anomalies,2017,57(5):142-149.[17]Ilhan N,Kucuksu M,Kaman D,et al.The 677 C/T MTHFR Polymorphism is Associated with Essential Hypertension, Coronary Artery Disease,and Higher Homocysteine Levels[J].Archives of Medical Research,2008,39(1):125-130.[18]Chen YY,Wang BN,Yu XP.Correlation between the 677C>T polymorphism in the methylene tetrahydrofolate reductase gene and serum homocysteine levels in coronary heart disease[J].Genetics and Molecular Research,2016,15(1):10.4238/gmr.15017238.[19]Mehlig K,Leander K,Faire UD,et al.The association between plasma homocysteine and coronary heart disease is modified by the MTHFR 677C>T polymorphism[J].Heart,2013,99(23):1761-1765.[20]Rallidis LS,Gialeraki A,Komporozos C,et al.Role of methylenetetrahydrofolate reductase 677C>T polymorphism in the development of premature myocardial infarction[J].Atherosclerosis,2008,200(1):115-120.[21]van Meurs JB,Pare G,Schwartz SM,et al.Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease[J].Am J Clin Nutr,2013,98(3):668-676.[22]Bickel C,Schnabel RB,Zengin E,et al.Homocysteine concentration in coronary artery disease:Influence of three common single nucleotide polymorphisms[J].Nutr Metab Cardiovasc Dis,2017,27(2):168-175.[23]Cui R,Iso H,Date C,et al.Dietary Folate and Vitamin B6 and B12 Intake in Relation to Mortality From Cardiovascular Diseases:Japan Collaborative Cohort Study[J].Stroke,2010,41(6):1285-1289.[24]Huang T,Chen Y,Yang B,et al.Meta-analysis of B vitamin supplementation on plasma homocysteine,cardiovascular and all-cause mortality[J].Clin Nutr,2012,31(4):448-454.[25]Armitage JM,Bowman L,Clarke RJ,et al.Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors:a randomized trial[J].JAMA,2010,303(24):2486-2494.[26]Zhang C,Wang ZY,Qin YY,et al.Association between B vitamins supplementation and risk of cardiovascular outcomes:a cumulative meta-analysis of randomized controlled trials[J].PLoS One,2014,9(9):e107060.[27]Martí-Carvajal AJ,Solà I,Lathyris D,et al.Homocysteine-lowering interventions for preventing cardiovascular events[J].Cochrane Database Syst Rev,2017(8):CD006612.
相似文献/References:
[1]张挺挺.经股和桡动脉介入治疗冠心病的临床疗效对比[J].医学信息,2018,31(03):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
ZHANG Ting-ting.Comparison of Clinical Effects of Interventional Treatment of Coronary Heart Disease by Femoral and Radial Artery[J].Medical Information,2018,31(09):114.[doi:10.3969/j.issn.1006-1959.2018.03.038]
[2]迮艳华.稳心颗粒联合美托洛尔治疗冠心病心律失常的疗效分析[J].医学信息,2018,31(03):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
ZE Yan-hua.Therapeutic Effect of Wenxin Granule Combined with Metoprolol on Arrhythmia of Coronary Heart Disease[J].Medical Information,2018,31(09):139.[doi:10.3969/j.issn.1006-1959.2018.03.049]
[3]张 旭.冠心病心绞痛患者进行护理干预的临床效果及
对护理质量影响研究[J].医学信息,2018,31(05):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
ZHANG Xu.Clinical Effect of Nursing Intervention in Patients with Angina Pectoris of Coronary Heart Disease and its Influence on Nursing Quality[J].Medical Information,2018,31(09):182.[doi:10.3969/j.issn.1006-1959.2018.05.068]
[4]向明明,赵晓辉.黑龙江省东部地区汉族人群冠心病的危险因素研究[J].医学信息,2018,31(07):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
XIANG Ming-ming,ZHAO Xiao-hui.Study on Risk Factors of Coronary Heart Disease in Han Nationality Population in Eastern Heilongjiang Province[J].Medical Information,2018,31(09):122.[doi:10.3969/j.issn.1006-1959.2018.07.041]
[5]王 坤,张永春.血清胆红素水平、单核细胞数、红细胞分布宽度与
冠状动脉病变程度的关系[J].医学信息,2018,31(08):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
WANG Kun,ZHANG Yong-chun.Relationship between Serum Bilirubin Level,Monocyte Count,Red Blood Cell Distribution Width and Severity of Coronary Artery Disease[J].Medical Information,2018,31(09):53.[doi:10.3969/j.issn.1006-1959.2018.08.017]
[6]毛红岩.冠状动脉介入治疗冠心病的疗效及
对患者血清炎症因子的影响[J].医学信息,2018,31(10):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
MAO Hong-yan.Effect of Coronary Intervention on Coronary Heart Disease and its Influence on Serum Inflammatory Factors[J].Medical Information,2018,31(09):77.[doi:10.3969/j.issn.1006-1959.2018.10.023]
[7]杨锦龙,刘 欢,吕秋菊,等.非糖尿病患者糖化血红蛋白和胰岛素抵抗与
冠状动脉病变程度的相关性研究[J].医学信息,2018,31(10):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
YANG Jin-long,LIU Huan,LV Qiu-ju,et al.Correlation between Glycosylated Hemoglobin and Insulin Resistance and Severity of Coronary Artery Disease in Non-diabetic Patients[J].Medical Information,2018,31(09):93.[doi:10.3969/j.issn.1006-1959.2018.10.028]
[8]李 铎,王建华.盐酸曲美他嗪片辅助治疗对冠心病伴心力衰竭患者氧化应激、心肌功能的影响[J].医学信息,2018,31(10):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
LI Duo,WANG Jian-hua.Effect of Trimetazidine Hydrochloride Tablets Adjuvant Therapy on Oxidative Stress and Myocardial Function in Patients with Coronary Heart Disease Complicated with Heart Failure[J].Medical Information,2018,31(09):126.[doi:10.3969/j.issn.1006-1959.2018.10.041]
[9]田跃雷.冠心病介入治疗后再狭窄的中西医防治[J].医学信息,2022,35(09):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
TIAN Yue-lei.Prevention and Treatment of Restenosis After Percutaneous Coronary Intervention with Chinese and Western Medicine[J].Medical Information,2022,35(09):46.[doi:10.3969/j.issn.1006-1959.2022.09.011]
[10]宫丽萍.血府逐瘀汤加减治疗气滞血瘀型冠心病心绞痛的疗效研究[J].医学信息,2018,31(12):145.[doi:10.3969/j.issn.1006-1959.2018.12.046]
GONG Li-ping.Therapeutic Effect of Xuefu Zhuyu Decoction on Angina Pectoris with Qi Stagnation and Blood Stasis[J].Medical Information,2018,31(09):145.[doi:10.3969/j.issn.1006-1959.2018.12.046]
[11]袁 帅,邢晓博,李 晓,等.MTHFR基因多态性与中年男性冠状动脉病变程度的相关研究[J].医学信息,2018,31(03):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
YUAN Shuai,XING Xiao-bo,LI Xiao,et al.Association of MTHFR Gene Polymorphism with Coronary Artery Lesions in Middle-aged Men[J].Medical Information,2018,31(09):67.[doi:10.3969/j.issn.1006-1959.2018.03.021]
[12]张 波.冠心病心绞痛患者血浆同型半胱氨酸水平与
中医证候要素痰、瘀的回归性研究[J].医学信息,2018,31(16):142.[doi:10.3969/j.issn.1006-1959.2018.16.045]
ZHANG Bo.A Regression Study of Plasma Homocysteine Level and Phlegm and Blood Stasis in Patients with Angina Pectoris of Coronary Heart Disease[J].Medical Information,2018,31(09):142.[doi:10.3969/j.issn.1006-1959.2018.16.045]
[13]张晓瑛,李雯彬,张志虹,等.同型半胱氨酸、抑郁症状与冠心病的研究进展[J].医学信息,2019,32(11):22.[doi:10.3969/j.issn.1006-1959.2019.11.007]
ZHANG Xiao-ying,LI Wen-bin,ZHANG Zhi-hong,et al.Advances in Research on Homocysteine,Depressive Symptoms and Coronary Heart Disease[J].Medical Information,2019,32(09):22.[doi:10.3969/j.issn.1006-1959.2019.11.007]
[14]周忠梅.前列地尔辅助常规治疗冠心病不稳定型心绞痛的效果及对患者凝血功能的影响[J].医学信息,2019,32(20):147.[doi:10.3969/j.issn.1006-1959.2019.20.046]
ZHOU Zhong-mei.Effect of Alprostadil on Routine Treatment of Unstable Angina Pectoris in Coronary Heart Disease and its Effect on Coagulation Function in Patients[J].Medical Information,2019,32(09):147.[doi:10.3969/j.issn.1006-1959.2019.20.046]
[15]张盼盼,薛 凌.PCSK9及Hcy水平对冠心病患者的临床意义[J].医学信息,2020,33(08):73.[doi:10.3969/j.issn.1006-1959.2020.08.024]
ZHANG Pan-pan,XUE Ling.Clinical Significance of PCSK9 and Hcy Levels in Patients with Coronary Heart Disease[J].Medical Information,2020,33(09):73.[doi:10.3969/j.issn.1006-1959.2020.08.024]
[16]赵晓静,鲁作华,韩书光,等.同型半胱氨酸、C反应蛋白及心肌标志物与冠心病早期诊断的相关研究[J].医学信息,2022,35(14):135.[doi:10.3969/j.issn.1006-1959.2022.14.034]
ZHAO Xiao-jing,LU Zuo-hua,HAN Shu-guang,et al.Correlation of Homocysteine, C-reactive Protein and Myocardial Markers with Early Diagnosis of Coronary Heart Disease[J].Medical Information,2022,35(09):135.[doi:10.3969/j.issn.1006-1959.2022.14.034]